The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 343:661-662 August 31, 2000 Number 9
NextNext

New Treatment Options for Bartter's Syndrome

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Bartter's syndrome is a major cause of congenital salt wasting. As a consequence of abnormal salt reabsorption in the thick ascending limb of Henle's loop due to mutations in the luminal sodium–potassium-2–chloride cotransporter (antenatal Bartter's syndrome type I), the luminal potassium channel (antenatal Bartter's syndrome type II), or the basolateral chloride channel (classic Bartter's syndrome type III), the activity of the renin–angiotensin–aldosterone system increases.1 Prostaglandins increase as a consequence of volume contraction, and this increase may itself stimulate renin secretion.2 Unfortunately, prostaglandins block salt reabsorption by mechanisms that are not yet fully understood.1

The clinical problems in . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.